Recommendations stated in the TASC II guidelines for the treatment of peripheral arterial
disease (PAD) regard a heterogeneous group of patients ranging from claudicants to critical …

BACKGROUND: The invasive treatment of chronic lower extremity peripheral arterial
disease (PAD) has become inconsistent. To standardize treatment at our institution, the …

Objective The clinical implication of the coronary artery calcium score (CS) is well
demonstrated. However, little is known about the association between lower extremity …

Objective African Americans (AAs) with symptomatic peripheral arterial disease (PAD) have
been reported to have fewer revascularization attempts and poorer patency and limb …

Aims Only few and historic studies reported a bad prognosis of peripheral arterial disease
(PAD) and critical limb ischaemia (CLI). The contemporary state of treatment and outcomes …

Background: Patients presenting with critical limb-threatening ischemia (CLTI) have been
increasing in number over the years. They represent a high-risk population, especially in …

Background: Acute limb ischemia (ALI) is an important clinical event and an emerging
cardiovascular clinical trial outcome. Risk factors for and outcomes after ALI have not been …

Guideline Summary Chronic limb-threatening ischemia (CLTI) is associated with mortality,
amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are …

Lower extremity critical limb ischemia (CLI) represents symptoms related to end-stage
atherosclerotic peripheral arterial disease manifested by rest pain and tissue loss. It is …

AIM: To assess the utility of 64 section multidetector computed tomography (MDCT) lower-
limb angiography in the evaluation of patients with critical limb ischaemia (CLI) or severe …